https://envisagenics.com 2025-12-17T22:29:56.459Z yearly 1 https://envisagenics.com/about 2025-12-17T22:29:56.459Z yearly 0.5 https://envisagenics.com/science 2025-12-17T22:29:56.459Z yearly 1 https://envisagenics.com/pipeline 2025-12-17T22:29:56.459Z yearly 0.8 https://envisagenics.com/careers 2025-12-17T22:29:56.459Z yearly 0.3 https://envisagenics.com/contact 2025-12-17T22:29:56.459Z yearly 0.3 https://envisagenics.com/privacy-policy 2025-12-17T22:29:56.459Z monthly 0.1 https://envisagenics.com/news/former-departmental-cso-of-eli-lilly-joins-envisagenics-board-of-directors 2025-12-17T22:29:56.979Z never 0.5 https://envisagenics.com/news/envisagenics-raises-series-b-to-fuel-ai-enabled-novel-therapeutic-pipeline-and-expand-depth-and-breadth-of-commercial-offerings 2025-12-17T22:29:56.979Z never 0.5 https://envisagenics.com/news/results-from-evaluation-of-the-company-s-splice-core-ai-ml-platform-in-triple-negative-breast-cancer-published-in-molecular-systems-biology 2025-12-17T22:29:56.979Z never 0.5 https://envisagenics.com/news/envisagenics-cancer-research-horizons-and-queen-mary-university-of-london-announce-strategic-collaboration-agreement 2025-12-17T22:29:56.979Z never 0.5 https://envisagenics.com/news/envisagenics-announces-research-collaboration-with-bristol-myers-squibb 2025-12-17T22:29:56.979Z never 0.5 https://envisagenics.com/news/oxford-global-biologics-analysis-insight-article-the-black-box-effect-how-can-ai-and-ml-provide-transparent-insights-for-drug-discovery 2025-12-17T22:29:56.979Z never 0.5 https://envisagenics.com/news/envisagenics-is-awarded-another-sbir-grant-from-the-national-cancer-institute-to-commercialize-its-ai-ml-platform-for-immunotherapy-development 2025-12-17T22:29:56.979Z never 0.5 https://envisagenics.com/news/alliance-for-artificial-intelligence-in-healthcare-elects-new-board-leadership-for-2022 2025-12-17T22:29:56.979Z never 0.5 https://envisagenics.com/news/envisagenics-raises-series-a-financing-to-scale-its-ai-powered-rna-splicing-drug-discovery-platform 2025-12-17T22:29:56.979Z never 0.5 https://envisagenics.com/news/biogen-and-envisagenics-announce-collaboration-to-advance-rna-splicing-research 2025-12-17T22:29:56.979Z never 0.5 https://envisagenics.com/news/envisagenics-announces-research-program-with-the-lung-cancer-initiative-at-johnson-and-johnson 2025-12-17T22:29:56.979Z never 0.5 https://envisagenics.com/news/envisagenics-wins-another-sbir-grant-from-the-national-cancer-institute-to-enhance-their-ai-ml-platform-for-immunotherapy-development 2025-12-17T22:29:56.979Z never 0.5 https://envisagenics.com/news/national-institutes-of-health-awards-envisagenics-with-1-5-m-phase-ii-sbir-grant 2025-12-17T22:29:56.979Z never 0.5 https://envisagenics.com/news/envisagenics-named-north-american-winner-of-innovate-ai-competition 2025-12-17T22:29:56.979Z never 0.5 https://envisagenics.com/news/envisagenics-closes-2-35-m-seed-round-and-launches-splice-core-platform 2025-12-17T22:29:56.979Z never 0.5